Durable Medical Equipment Market by Product Type (Hospital Beds, Patient Lifts, Patient Monitors), End User (Ambulatory Surgical Centers, Clinics, Home Care), Distribution Channel, Purchase Mode - Global Forecast 2025-2032
Description
The Durable Medical Equipment Market was valued at USD 220.08 billion in 2024 and is projected to grow to USD 230.38 billion in 2025, with a CAGR of 5.91%, reaching USD 348.52 billion by 2032.
A concise industry overview framing the strategic importance of durable medical equipment for care delivery, reimbursement, and patient-centered outcomes
Durable medical equipment plays a pivotal role in modern care delivery, enabling hospitals, clinics, home care providers, and long-term care facilities to deliver higher-quality, cost-effective services. Advances in device connectivity, remote monitoring, and user-centered design are shifting the function of these products from discrete assets into integral components of care pathways. As reimbursement models evolve and value-based care gains traction, stakeholders increasingly demand equipment that supports clinical outcomes, operational efficiency, and patient experience.
This overview situates durable medical equipment within broader health system priorities, emphasizing interoperability, ease of use, and lifecycle cost management. Increasingly, procurement decisions are influenced by total cost of ownership, service and maintenance models, and the ability to integrate data streams into electronic health records and population health platforms. Manufacturers, distributors, and providers must therefore align product development and commercialization strategies with the realities of decentralized care, constrained capital budgets, and heightened regulatory scrutiny.
In the sections that follow, the analysis explores how technology adoption, tariff-driven supply chain adjustments, segmentation dynamics, regional nuances, and competitive behaviors together create a complex environment that requires both operational discipline and strategic agility.
Identifying transformative shifts reshaping the durable medical equipment landscape including technology integration, care decentralization, and sustainability imperatives
The durable medical equipment landscape is being reshaped by several concurrent transformative shifts that are redefining competitive positions and investment priorities. First, digitalization and device connectivity are moving equipment from isolated tools to data-generating endpoints that support remote patient monitoring, predictive maintenance, and clinical decision support. This transition elevates software capabilities and cybersecurity considerations alongside traditional hardware design and service models.
Second, care delivery is decentralizing as more procedures and long-term care move into ambulatory settings and home environments. This trend increases demand for portable, user-friendly, and remotely supported equipment that maintains clinical efficacy outside the hospital. Third, supply chain resilience has become a strategic priority; manufacturers and distributors are diversifying sourcing, redesigning inventories, and investing in nearshoring to reduce exposure to geopolitical and logistics disruptions.
Finally, sustainability and total lifecycle considerations are influencing procurement and product development decisions. Buyers are prioritizing devices that offer repairability, energy efficiency, and end-of-life planning. Taken together, these shifts require integrated strategies that balance innovation, regulatory compliance, and operational execution to capture emerging opportunities and mitigate systemic risks.
Assessing the cumulative implications of United States tariffs in 2025 on supply chains, manufacturing strategies, pricing pressures, and cross-border procurement resilience
Tariff policy adjustments announced in the United States for 2025 are creating a recalibration across manufacturing, procurement, and pricing strategies in the durable medical equipment space. The immediate operational response among manufacturers has focused on supply chain reconfiguration, including diversifying supplier bases, increasing inventory buffers for key components, and accelerating qualification of alternate sourcing to maintain continuity of production and distribution.
Procurement teams within hospitals, clinics, ambulatory surgical centers, long-term care facilities, and home care networks are revisiting supplier contracts and service-level agreements to account for potential cost variability and lead-time volatility. Distributors and specialty retailers are reassessing inventory strategies and pricing frameworks to preserve margins while maintaining competitiveness, particularly in channels where price sensitivity is high.
In parallel, manufacturers are examining design and materials decisions to reduce tariff exposure by substituting components, consolidating part counts, or shifting manufacturing stages across jurisdictions. Investments in automation and process efficiency are being prioritized to offset tariff-related cost pressures and to protect profitability without compromising product quality or clinical performance. These adaptations underscore the need for scenario planning and flexible commercial models that can absorb policy-driven cost shocks.
Key segmentation insights revealing demand differentials across product types, end users, distribution channels, and purchase modes that guide go-to-market strategies
Segmentation dynamics reveal differentiated demand patterns and strategic priorities across product types, end users, distribution channels, and purchase modes. Within product type, hospital beds-including adjustable beds and stretchers-remain central to acute care operations and prioritize durability, infection-control features, and ease of customization; patient lifts, both electric and hydraulic variants, are increasingly evaluated for caregiver ergonomics and patient safety features; patient monitors such as ECG monitors, fetal monitors, and vital signs devices are being selected for interoperability, alarm management, and remote monitoring capabilities; respiratory equipment comprising CPAP machines, oxygen concentrators, and ventilators places a premium on reliability, quiet operation, and serviceability, with oxygen concentrators further divided between portable and stationary solutions and ventilators classified into invasive and noninvasive types; wheelchairs split between manual and powered platforms are judged on maneuverability, weight, and battery and maintenance ecosystems.
End-user segmentation shows that hospitals and long-term care facilities focus on robustness, compliance, and centralized servicing, while ambulatory surgical centers and clinics prioritize throughput and portability. Home care demands bring user-friendly interfaces, telesupport, and safety certifications to the fore. Distribution channel distinctions matter: direct sales relationships are favored for complex procurements that require customization and integration, online channels accelerate access for commoditized products where price and speed matter, retail and specialty stores support outpatient and consumer-facing purchases and facilitate product trial and service touchpoints. Purchase mode drives different commercial models; rental suits short-term needs and capital-constrained providers with service bundles, whereas outright sale aligns with ownership models seeking longer-term lifecycle economics. These segmentation lenses guide product roadmaps, service offerings, and channel investments to align with buyer preferences and clinical workflows.
Regional perspectives translating macroeconomic, regulatory, and care-delivery differences across the Americas, Europe Middle East and Africa, and Asia-Pacific into market priorities
Regional dynamics create distinct strategic imperatives for manufacturers, distributors, and providers across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, procurement emphasis often balances cost discipline with rapid adoption of remote-monitoring and telehealth-enabled devices, driven by payer mix and evolving care delivery models. Regulatory pathways and reimbursement frameworks in this region shape demand for interoperable, well-documented devices and influence service contract structures.
In Europe, the Middle East and Africa, the landscape is heterogeneous; Western Europe prioritizes sustainability, strict regulatory compliance, and integration with national health systems, while emerging markets in the Middle East and Africa are characterized by infrastructure investment, public–private partnerships, and demand for durable, cost-effective equipment adapted to local maintenance capabilities. This region also places increasing importance on circular economy practices.
Asia-Pacific presents a mix of advanced manufacturing capabilities, rapid adoption of mobile-enabled health solutions, and varied regulatory regimes. Several markets within the region are scaling domestic production, offering suppliers opportunities to localize manufacturing and to participate in regional supply chains. Across all regions, companies that align product design, distribution approaches, and after-sales service models with local reimbursement, clinical practice patterns, and logistical realities will be better positioned to secure durable commercial relationships.
Competitive and corporate behavior insights highlighting product innovation, strategic partnerships, manufacturing footprint shifts, and risk management approaches among leading players
Leading companies in the durable medical equipment domain are adopting multi-pronged strategies that combine product innovation, channel expansion, and operational resilience. Innovation is increasingly centered on software-enabled features, modular designs that simplify servicing and upgrades, and interoperability frameworks that allow devices to feed clinical workflows and analytics platforms. At the same time, firms are forging strategic partnerships with health systems, technology vendors, and service providers to co-develop solutions and to accelerate adoption curves.
Operationally, companies are investing in supply chain diversification, supplier qualification programs, and near-term capacity realignment to reduce exposure to single-source dependencies and tariff-driven disruptions. Commercial models are evolving as well; rental and subscription-based approaches are being bundled with remote support and predictive maintenance to create recurring revenue streams and to address buyer preferences for lower upfront costs. Mergers, acquisitions, and distribution agreements continue as mechanisms to access new geographies, expand product portfolios, and consolidate aftermarket services. Overall, competitive advantage is accruing to firms that combine clinical insight, manufacturing excellence, and a service-centric go-to-market orientation.
Actionable recommendations for industry leaders to accelerate adoption, protect margins, optimize supply chains, and expand access across channels and care settings
Industry leaders should prioritize four interlocking actions to secure durable strategic advantage: accelerate the integration of digital capabilities into hardware products, aligning device software, cybersecurity, and data interoperability with buyer IT systems; redesign supply chain architecture to incorporate dual sourcing, nearshoring where feasible, and inventory strategies that improve responsiveness without eroding margins; evolve commercial models to offer flexible purchase modes such as rental, managed services, and bundled maintenance that address capital constraints and operational burden for providers; and embed sustainability and lifecycle planning into product design and service offerings to meet regulatory and procurement preferences focused on repairability and environmental impact.
These actions should be implemented through cross-functional programs that link R&D, regulatory, supply chain, and commercial teams. Leadership should also invest in capabilities for real-world evidence generation and post-market surveillance to demonstrate clinical value and to strengthen payer conversations. Finally, scenario-based planning and stress-testing of supply chains and pricing models will enable organizations to respond rapidly to policy shifts and geopolitical disruptions, preserving service continuity and competitive positioning.
Transparent research methodology describing primary and secondary approaches, expert engagement, data triangulation, and validation techniques underpinning the analysis
The analysis underpinning this executive summary is grounded in a blended methodology that combines primary stakeholder engagement, rigorous secondary source synthesis, and iterative validation. Primary research included structured interviews with clinical leaders, procurement professionals across ambulatory surgical centers, hospitals, long-term care facilities, home health operators, and executives from manufacturing and distribution organizations to capture firsthand perspectives on procurement drivers, service expectations, and technology priorities.
Secondary research involved systematic review of regulatory guidance, standards, patent activity, and industry reporting to contextualize technology trends and policy changes. Data triangulation techniques were used to reconcile disparate inputs, identify consistent themes, and surface areas of uncertainty. Throughout the process, findings were peer-reviewed by subject-matter experts with experience in clinical engineering, supply chain management, and health policy to ensure factual accuracy and practical relevance.
Limitations of the methodology include variability across local regulatory regimes and the evolving nature of tariff policy, both of which require ongoing monitoring. To mitigate these limitations, the approach emphasizes transparency in source attribution and the use of sensitivity analyses to highlight where assumptions materially influence strategic conclusions.
A concise conclusion synthesizing strategic implications for stakeholders and outlining priority focus areas for investment, innovation, and operational resilience
The combined insights from technology trends, tariff-driven supply chain adjustments, nuanced segmentation dynamics, and regional variations point to a clear strategic imperative: organizations must be simultaneously innovative and pragmatic. Devices that integrate data and support decentralization of care will capture growing attention from providers seeking to improve outcomes and control costs, while operational excellence in sourcing and aftermarket services will determine the sustainability of margins.
Strategic focus areas include enhancing device interoperability, expanding service-oriented commercial models, and localizing manufacturing or distribution footprints where economically sensible. Stakeholders that implement these measures in alignment with regional regulatory and reimbursement realities will be better positioned to win long-term contracts and to influence standards of care. In short, success will require coordinated action across product development, supply chain, commercial, and regulatory functions to translate technological potential into durable commercial advantage.
Please Note: PDF & Excel + Online Access - 1 Year
A concise industry overview framing the strategic importance of durable medical equipment for care delivery, reimbursement, and patient-centered outcomes
Durable medical equipment plays a pivotal role in modern care delivery, enabling hospitals, clinics, home care providers, and long-term care facilities to deliver higher-quality, cost-effective services. Advances in device connectivity, remote monitoring, and user-centered design are shifting the function of these products from discrete assets into integral components of care pathways. As reimbursement models evolve and value-based care gains traction, stakeholders increasingly demand equipment that supports clinical outcomes, operational efficiency, and patient experience.
This overview situates durable medical equipment within broader health system priorities, emphasizing interoperability, ease of use, and lifecycle cost management. Increasingly, procurement decisions are influenced by total cost of ownership, service and maintenance models, and the ability to integrate data streams into electronic health records and population health platforms. Manufacturers, distributors, and providers must therefore align product development and commercialization strategies with the realities of decentralized care, constrained capital budgets, and heightened regulatory scrutiny.
In the sections that follow, the analysis explores how technology adoption, tariff-driven supply chain adjustments, segmentation dynamics, regional nuances, and competitive behaviors together create a complex environment that requires both operational discipline and strategic agility.
Identifying transformative shifts reshaping the durable medical equipment landscape including technology integration, care decentralization, and sustainability imperatives
The durable medical equipment landscape is being reshaped by several concurrent transformative shifts that are redefining competitive positions and investment priorities. First, digitalization and device connectivity are moving equipment from isolated tools to data-generating endpoints that support remote patient monitoring, predictive maintenance, and clinical decision support. This transition elevates software capabilities and cybersecurity considerations alongside traditional hardware design and service models.
Second, care delivery is decentralizing as more procedures and long-term care move into ambulatory settings and home environments. This trend increases demand for portable, user-friendly, and remotely supported equipment that maintains clinical efficacy outside the hospital. Third, supply chain resilience has become a strategic priority; manufacturers and distributors are diversifying sourcing, redesigning inventories, and investing in nearshoring to reduce exposure to geopolitical and logistics disruptions.
Finally, sustainability and total lifecycle considerations are influencing procurement and product development decisions. Buyers are prioritizing devices that offer repairability, energy efficiency, and end-of-life planning. Taken together, these shifts require integrated strategies that balance innovation, regulatory compliance, and operational execution to capture emerging opportunities and mitigate systemic risks.
Assessing the cumulative implications of United States tariffs in 2025 on supply chains, manufacturing strategies, pricing pressures, and cross-border procurement resilience
Tariff policy adjustments announced in the United States for 2025 are creating a recalibration across manufacturing, procurement, and pricing strategies in the durable medical equipment space. The immediate operational response among manufacturers has focused on supply chain reconfiguration, including diversifying supplier bases, increasing inventory buffers for key components, and accelerating qualification of alternate sourcing to maintain continuity of production and distribution.
Procurement teams within hospitals, clinics, ambulatory surgical centers, long-term care facilities, and home care networks are revisiting supplier contracts and service-level agreements to account for potential cost variability and lead-time volatility. Distributors and specialty retailers are reassessing inventory strategies and pricing frameworks to preserve margins while maintaining competitiveness, particularly in channels where price sensitivity is high.
In parallel, manufacturers are examining design and materials decisions to reduce tariff exposure by substituting components, consolidating part counts, or shifting manufacturing stages across jurisdictions. Investments in automation and process efficiency are being prioritized to offset tariff-related cost pressures and to protect profitability without compromising product quality or clinical performance. These adaptations underscore the need for scenario planning and flexible commercial models that can absorb policy-driven cost shocks.
Key segmentation insights revealing demand differentials across product types, end users, distribution channels, and purchase modes that guide go-to-market strategies
Segmentation dynamics reveal differentiated demand patterns and strategic priorities across product types, end users, distribution channels, and purchase modes. Within product type, hospital beds-including adjustable beds and stretchers-remain central to acute care operations and prioritize durability, infection-control features, and ease of customization; patient lifts, both electric and hydraulic variants, are increasingly evaluated for caregiver ergonomics and patient safety features; patient monitors such as ECG monitors, fetal monitors, and vital signs devices are being selected for interoperability, alarm management, and remote monitoring capabilities; respiratory equipment comprising CPAP machines, oxygen concentrators, and ventilators places a premium on reliability, quiet operation, and serviceability, with oxygen concentrators further divided between portable and stationary solutions and ventilators classified into invasive and noninvasive types; wheelchairs split between manual and powered platforms are judged on maneuverability, weight, and battery and maintenance ecosystems.
End-user segmentation shows that hospitals and long-term care facilities focus on robustness, compliance, and centralized servicing, while ambulatory surgical centers and clinics prioritize throughput and portability. Home care demands bring user-friendly interfaces, telesupport, and safety certifications to the fore. Distribution channel distinctions matter: direct sales relationships are favored for complex procurements that require customization and integration, online channels accelerate access for commoditized products where price and speed matter, retail and specialty stores support outpatient and consumer-facing purchases and facilitate product trial and service touchpoints. Purchase mode drives different commercial models; rental suits short-term needs and capital-constrained providers with service bundles, whereas outright sale aligns with ownership models seeking longer-term lifecycle economics. These segmentation lenses guide product roadmaps, service offerings, and channel investments to align with buyer preferences and clinical workflows.
Regional perspectives translating macroeconomic, regulatory, and care-delivery differences across the Americas, Europe Middle East and Africa, and Asia-Pacific into market priorities
Regional dynamics create distinct strategic imperatives for manufacturers, distributors, and providers across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, procurement emphasis often balances cost discipline with rapid adoption of remote-monitoring and telehealth-enabled devices, driven by payer mix and evolving care delivery models. Regulatory pathways and reimbursement frameworks in this region shape demand for interoperable, well-documented devices and influence service contract structures.
In Europe, the Middle East and Africa, the landscape is heterogeneous; Western Europe prioritizes sustainability, strict regulatory compliance, and integration with national health systems, while emerging markets in the Middle East and Africa are characterized by infrastructure investment, public–private partnerships, and demand for durable, cost-effective equipment adapted to local maintenance capabilities. This region also places increasing importance on circular economy practices.
Asia-Pacific presents a mix of advanced manufacturing capabilities, rapid adoption of mobile-enabled health solutions, and varied regulatory regimes. Several markets within the region are scaling domestic production, offering suppliers opportunities to localize manufacturing and to participate in regional supply chains. Across all regions, companies that align product design, distribution approaches, and after-sales service models with local reimbursement, clinical practice patterns, and logistical realities will be better positioned to secure durable commercial relationships.
Competitive and corporate behavior insights highlighting product innovation, strategic partnerships, manufacturing footprint shifts, and risk management approaches among leading players
Leading companies in the durable medical equipment domain are adopting multi-pronged strategies that combine product innovation, channel expansion, and operational resilience. Innovation is increasingly centered on software-enabled features, modular designs that simplify servicing and upgrades, and interoperability frameworks that allow devices to feed clinical workflows and analytics platforms. At the same time, firms are forging strategic partnerships with health systems, technology vendors, and service providers to co-develop solutions and to accelerate adoption curves.
Operationally, companies are investing in supply chain diversification, supplier qualification programs, and near-term capacity realignment to reduce exposure to single-source dependencies and tariff-driven disruptions. Commercial models are evolving as well; rental and subscription-based approaches are being bundled with remote support and predictive maintenance to create recurring revenue streams and to address buyer preferences for lower upfront costs. Mergers, acquisitions, and distribution agreements continue as mechanisms to access new geographies, expand product portfolios, and consolidate aftermarket services. Overall, competitive advantage is accruing to firms that combine clinical insight, manufacturing excellence, and a service-centric go-to-market orientation.
Actionable recommendations for industry leaders to accelerate adoption, protect margins, optimize supply chains, and expand access across channels and care settings
Industry leaders should prioritize four interlocking actions to secure durable strategic advantage: accelerate the integration of digital capabilities into hardware products, aligning device software, cybersecurity, and data interoperability with buyer IT systems; redesign supply chain architecture to incorporate dual sourcing, nearshoring where feasible, and inventory strategies that improve responsiveness without eroding margins; evolve commercial models to offer flexible purchase modes such as rental, managed services, and bundled maintenance that address capital constraints and operational burden for providers; and embed sustainability and lifecycle planning into product design and service offerings to meet regulatory and procurement preferences focused on repairability and environmental impact.
These actions should be implemented through cross-functional programs that link R&D, regulatory, supply chain, and commercial teams. Leadership should also invest in capabilities for real-world evidence generation and post-market surveillance to demonstrate clinical value and to strengthen payer conversations. Finally, scenario-based planning and stress-testing of supply chains and pricing models will enable organizations to respond rapidly to policy shifts and geopolitical disruptions, preserving service continuity and competitive positioning.
Transparent research methodology describing primary and secondary approaches, expert engagement, data triangulation, and validation techniques underpinning the analysis
The analysis underpinning this executive summary is grounded in a blended methodology that combines primary stakeholder engagement, rigorous secondary source synthesis, and iterative validation. Primary research included structured interviews with clinical leaders, procurement professionals across ambulatory surgical centers, hospitals, long-term care facilities, home health operators, and executives from manufacturing and distribution organizations to capture firsthand perspectives on procurement drivers, service expectations, and technology priorities.
Secondary research involved systematic review of regulatory guidance, standards, patent activity, and industry reporting to contextualize technology trends and policy changes. Data triangulation techniques were used to reconcile disparate inputs, identify consistent themes, and surface areas of uncertainty. Throughout the process, findings were peer-reviewed by subject-matter experts with experience in clinical engineering, supply chain management, and health policy to ensure factual accuracy and practical relevance.
Limitations of the methodology include variability across local regulatory regimes and the evolving nature of tariff policy, both of which require ongoing monitoring. To mitigate these limitations, the approach emphasizes transparency in source attribution and the use of sensitivity analyses to highlight where assumptions materially influence strategic conclusions.
A concise conclusion synthesizing strategic implications for stakeholders and outlining priority focus areas for investment, innovation, and operational resilience
The combined insights from technology trends, tariff-driven supply chain adjustments, nuanced segmentation dynamics, and regional variations point to a clear strategic imperative: organizations must be simultaneously innovative and pragmatic. Devices that integrate data and support decentralization of care will capture growing attention from providers seeking to improve outcomes and control costs, while operational excellence in sourcing and aftermarket services will determine the sustainability of margins.
Strategic focus areas include enhancing device interoperability, expanding service-oriented commercial models, and localizing manufacturing or distribution footprints where economically sensible. Stakeholders that implement these measures in alignment with regional regulatory and reimbursement realities will be better positioned to win long-term contracts and to influence standards of care. In short, success will require coordinated action across product development, supply chain, commercial, and regulatory functions to translate technological potential into durable commercial advantage.
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
197 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Rapid adoption of IoT-enabled home-based ventilator systems for remote patient monitoring
- 5.2. Emergence of AI-powered predictive maintenance solutions for mobility aids
- 5.3. Growth of 3D printing customized prosthetic and orthotic devices in clinical settings
- 5.4. Integration of telehealth platforms with home infusion therapy for chronic conditions
- 5.5. Shift towards value-based reimbursement models driving DME provider service offerings
- 5.6. Expansion of rental and subscription-based business models for at-home medical equipment
- 5.7. Regulatory harmonization efforts influencing global supply of respiratory support devices
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Durable Medical Equipment Market, by Product Type
- 8.1. Hospital Beds
- 8.1.1. Adjustable
- 8.1.2. Stretchers
- 8.2. Patient Lifts
- 8.2.1. Electric
- 8.2.2. Hydraulic
- 8.3. Patient Monitors
- 8.3.1. ECG Monitors
- 8.3.2. Fetal Monitors
- 8.3.3. Vital Signs
- 8.4. Respiratory Equipment
- 8.4.1. CPAP Machines
- 8.4.2. Oxygen Concentrators
- 8.4.2.1. Portable
- 8.4.2.2. Stationary
- 8.4.3. Ventilators
- 8.4.3.1. Invasive
- 8.4.3.2. Noninvasive
- 8.5. Wheelchairs
- 8.5.1. Manual
- 8.5.2. Powered
- 9. Durable Medical Equipment Market, by End User
- 9.1. Ambulatory Surgical Centers
- 9.2. Clinics
- 9.3. Home Care
- 9.4. Hospitals
- 9.5. Long-Term Care Facilities
- 10. Durable Medical Equipment Market, by Distribution Channel
- 10.1. Direct Sales
- 10.2. Online
- 10.3. Retail
- 10.4. Specialty Stores
- 11. Durable Medical Equipment Market, by Purchase Mode
- 11.1. Rental
- 11.2. Sale
- 12. Durable Medical Equipment Market, by Region
- 12.1. Americas
- 12.1.1. North America
- 12.1.2. Latin America
- 12.2. Europe, Middle East & Africa
- 12.2.1. Europe
- 12.2.2. Middle East
- 12.2.3. Africa
- 12.3. Asia-Pacific
- 13. Durable Medical Equipment Market, by Group
- 13.1. ASEAN
- 13.2. GCC
- 13.3. European Union
- 13.4. BRICS
- 13.5. G7
- 13.6. NATO
- 14. Durable Medical Equipment Market, by Country
- 14.1. United States
- 14.2. Canada
- 14.3. Mexico
- 14.4. Brazil
- 14.5. United Kingdom
- 14.6. Germany
- 14.7. France
- 14.8. Russia
- 14.9. Italy
- 14.10. Spain
- 14.11. China
- 14.12. India
- 14.13. Japan
- 14.14. Australia
- 14.15. South Korea
- 15. Competitive Landscape
- 15.1. Market Share Analysis, 2024
- 15.2. FPNV Positioning Matrix, 2024
- 15.3. Competitive Analysis
- 15.3.1. 3Gen Consulting Services, LLP
- 15.3.2. Aero Mobility, Inc.
- 15.3.3. Arjo AB
- 15.3.4. Avante Health Solutions Company
- 15.3.5. Becton, Dickinson and Company
- 15.3.6. Braun Corporation
- 15.3.7. Cardinal Health
- 15.3.8. Carlisle Medical, Inc.
- 15.3.9. Compass Health Brands by Tenex Capital Management
- 15.3.10. GF Health Products, Inc.
- 15.3.11. Intco Medical Technology Co., Ltd.
- 15.3.12. Koninklijke Philips N.V.
- 15.3.13. Masimo Corporation
- 15.3.14. McKesson Corporation
- 15.3.15. Medline Industries, Inc.
- 15.3.16. Stryker Corporation
- 15.3.17. OMRON Healthcare Europe B.V.
- 15.3.18. Dexcom, Inc.
- 15.3.19. Cheelcare Store
- 15.3.20. Permobil AB
- 15.3.21. Pride Mobility Products Corporation
- 15.3.22. Ottobock SE & Co. KGaA
- 15.3.23. DJO, LLC
- 15.3.24. Invacare Corporation
- 15.3.25. Drive DeVilbiss Healthcare
- 15.3.26. Hill-Rom Holdings, Inc. by Baxter International Inc.
- 15.3.27. Sunrise Medical (US) LLC
- 15.3.28. Getinge AB
- 15.3.29. Medtronic PLC
- 15.3.30. GE HealthCare Technologies Inc.
- 15.3.31. Nihon Kohden America
- 15.3.32. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
